Paper4259147
[BAY a 1040--a highly potent Ca ++ -antagonistic inhibitor of electro-mechanical coupling processes in mammalian myocardium].
Fleckenstein A and 3 others. Arzneimittelforschung, 1972. Cited by 276 papers, by iCite.
Cite this record
ConductScience Library. [BAY a 1040--a highly potent Ca ++ -antagonistic inhibitor of electro-mechanical coupling processes in mammalian myocardium]. Papers, record 4259147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4259147
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- [BAY a 1040--a highly potent Ca ++ -antagonistic inhibitor of electro-mechanical coupling processes in mammalian myocardium].
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calcium | Major topic |
| Heart | Major topic |
| Nitrobenzenes | Major topic |
| Pyridines | Major topic |
| Vasodilator Agents | Major topic |
| Adenosine Triphosphatases | |
| Animals | |
| Cats | |
| Coronary Vessels | |
| Dicarboxylic Acids | |
| Guinea Pigs | |
| Membrane Potentials | |
| Muscle Contraction | |
| Muscle, Smooth | |
| Myocardium | |
| Myofibrils | |
| Oxygen Consumption | |
| Rabbits |
Source PubMed
Cited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 276 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41754776 | Conventional Antiarrhythmics Class I-IV, Late INa Inhibitors, IKs Enhancers, RyR2 Stabilizers, Gap Junction Modulators, Atrial-Selective Antiarrhythmics, and Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Therapy in Arrhythmias. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41754776 | PubMed |
| 39017590 | Exploring the multiple effects of nifedipine and captopril administration in spontaneously hypertensive rats through pharmacokinetic-pharmacodynamic analyses. | Pharmacol Res Perspect | 2024 | https://conductscience.org/library/papers/39017590 | PubMed |
| 32121306 | Strategies for Neuroprotection in Multiple Sclerosis and the Role of Calcium. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32121306 | PubMed |
| 28270844 | New generations of dihydropyridines for treatment of hypertension. | J Geriatr Cardiol | 2017 | https://conductscience.org/library/papers/28270844 | PubMed |
| 28123178 | Clinical roles of calcium channel blockers in ischemic heart diseases. | Hypertens Res | 2017 | https://conductscience.org/library/papers/28123178 | PubMed |
| 7426191 | Effect of nifedipine on exercise tolerance in angina pectoris. | Br Heart J | 1980 | https://conductscience.org/library/papers/7426191 | PubMed |
| 7219573 | Differential effects of organic slow inward current inhibitors, verapamil and nifedipine, on rate of atrioventricular rhythm and supraventricular tachycardia in the canine isolated, blood-perfused AV node preparation. | Naunyn Schmiedebergs Arch Pharmacol | 1981 | https://conductscience.org/library/papers/7219573 | PubMed |
| 7023517 | Role of calcium antagonists in cardiovascular therapy. | Br Heart J | 1981 | https://conductscience.org/library/papers/7023517 | PubMed |
| 7018149 | Modulation by verapamil of insulin and glucagon secretion in man. | Acta Diabetol Lat | 1981 | https://conductscience.org/library/papers/7018149 | PubMed |
| 7002569 | Impairment of insulin secretion in man by nifedipine. | Eur J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7002569 | PubMed |
| 6721841 | Properties of a new calcium ion antagonist on cellular uptake and mitochondrial efflux of calcium ions. | Biochem J | 1984 | https://conductscience.org/library/papers/6721841 | PubMed |
| 6628501 | Influence of verapamil on the inotropism and pharmacokinetics of digoxin. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6628501 | PubMed |
| 6430713 | The effect of nifedipine and verapamil on KC1-induced rhythmic contractions of guinea pig ureter in vitro. | Experientia | 1984 | https://conductscience.org/library/papers/6430713 | PubMed |
| 6339199 | Calcium antagonists. Clinical use in the treatment of angina. | Drugs | 1983 | https://conductscience.org/library/papers/6339199 | PubMed |
| 6112981 | Calcium antagonists: definition and mode of action. | Basic Res Cardiol | 1981 | https://conductscience.org/library/papers/6112981 | PubMed |
| 4859187 | [13-Norleucine-motiline--analysis of effects on the gastrointestinal tract]. | Naturwissenschaften | 1974 | https://conductscience.org/library/papers/4859187 | PubMed |
| 4627535 | [Influence of extracellular calcium concentration on the effect of coronary dilatators (action mechanism of coronary dilatators)]. | Pflugers Arch | 1972 | https://conductscience.org/library/papers/4627535 | PubMed |
| 4472867 | Calcium-antagonistic effects on the spontaneous activity of guinea-pig taenia coli. | Pflugers Arch | 1974 | https://conductscience.org/library/papers/4472867 | PubMed |
| 4282115 | Abolition by calcium antagonists of the autoregulation of renal blood flow. | Naunyn Schmiedebergs Arch Pharmacol | 1974 | https://conductscience.org/library/papers/4282115 | PubMed |
| 4271440 | Effects of "acute burn serum inhibitor" and "relaxing factors" on papillary muscles contractility. | Pflugers Arch | 1973 | https://conductscience.org/library/papers/4271440 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4259147
GET https://conductscience.org/api/papers/v1/4259147/cited_by?page=2